Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group.
Heininger U, Cherry JD, Stehr K, Schmitt-Grohé S, Uberall M, Laussucq S, Eckhardt T, Meyer M, Gornbein J. Heininger U, et al. Among authors: laussucq s. Pediatrics. 1998 Sep;102(3 Pt 1):546-53. doi: 10.1542/peds.102.3.546. Pediatrics. 1998. PMID: 9738175 Clinical Trial.
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.
Stehr K, Cherry JD, Heininger U, Schmitt-Grohé S, uberall M, Laussucq S, Eckhardt T, Meyer M, Engelhardt R, Christenson P. Stehr K, et al. Among authors: laussucq s. Pediatrics. 1998 Jan;101(1 Pt 1):1-11. doi: 10.1542/peds.101.1.1. Pediatrics. 1998. PMID: 9417143 Clinical Trial.
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Schmitt-Grohé S, Stehr K, Cherry JD, Heininger U, Uberall MA, Laussucq S, Eckhardt T. Schmitt-Grohé S, et al. Among authors: laussucq s. Dev Biol Stand. 1997;89:113-8. Dev Biol Stand. 1997. PMID: 9272341 Clinical Trial.
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Uberall MA, Stehr K, Cherry JD, Heininger U, Schmitt-Grohé S, Laussucq S, Eckhardt T. Uberall MA, et al. Among authors: laussucq s. Dev Biol Stand. 1997;89:83-9. Dev Biol Stand. 1997. PMID: 9272335 Clinical Trial.
Surrogate serologic tests for the prediction of pertussis vaccine efficacy.
Cherry JD, Heininger U, Christenson PD, Eckhardt T, Laussucq S, Hackell JG, Mezzatesta JR, Stehr K. Cherry JD, et al. Among authors: laussucq s. Ann N Y Acad Sci. 1995 May 31;754:359-63. doi: 10.1111/j.1749-6632.1995.tb44470.x. Ann N Y Acad Sci. 1995. PMID: 7625674 No abstract available.
Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
Vernacchio L, Bernstein H, Pelton S, Allen C, MacDonald K, Dunn J, Duncan DD, Tsao G, LaPosta V, Eldridge J, Laussucq S, Ambrosino DM, Molrine DC. Vernacchio L, et al. Among authors: laussucq s. Vaccine. 2002 Nov 1;20(31-32):3658-67. doi: 10.1016/s0264-410x(02)00413-9. Vaccine. 2002. PMID: 12399193 Clinical Trial.
11 results